Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2023 Earnings Presentation
16 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Jul 27, 2023
Slide 1: H1 Conference Call
H1 Conference Call Drägerwerk AG & Co. KGaA July 27, 2023, Lübeck Fußzeile: Bitte entsprechende Gesellschaft ergänzen
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials 6M 2023 03 Outlook FY 2023 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: Business development after successful H1 on track to return to growth and profitability in 2023
Business development after successful H1 on track to return to growth and profitability in 2023 • Strong net sales growth on the back of high orders on hand and an improving supply chain. • EBIT clearly positive due to net sales boost and successful price management. • Order intake in H1 almost on p
Slide 6: Financials 6M 2023
02 Financials 6M 2023 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry 6M 2022 6M 2023 Change Net sales (€ million) (fx-adj.) +21.1% +19.6% Europe 869.1 898.8 3.8% fx-adj fx-adj. +18.1% +17.7% Americas 316.0 305.0 -3.5% nominal nominal 1,532 AAA 462.5 392.9 -10.0% 1,302 771 Total 1,647.6 1,596.6 -1.5% 653 • Order entry slighty bel
Slide 8: Business development Medical
Business development Medical Order entry 6M 2022 6M 2023 Change Net sales (€ million) (fx-adj.) +15.5% +19.3% Europe 471.7 472.2 0.3% fx-adj fx-adj. +12.4% +17.2% Americas 209.0 187.1 -10.7% nominal nominal 911 AAA 316.1 258.2 -13.8% 777 441 Total 996.8 917.5 -6.5% 392 • Order entry below high prior
Slide 9: Business development Safety
Business development Safety Order entry 6M 2022 6M 2023 Change Net sales (€ million) (fx-adj.) +29.4% +20.0% Europe 397.3 426.6 7.9% fx-adj fx-adj. +26.7% +18.4% Americas 107.0 117.91 10.5% nominal nominal 622 AAA 146.5 134.6 -1.8% 525 330 Total 650.8 679.1 6.2% 261 • Order entry increased, driven b
Slide 10: Key figures
Key figures 6M 2023 6M 2022 Change € million € million % Cashflow (from operating activities) -7.3 -214.8 96.6 Investments 62.1 56.1 10.8 Cash and cash equivalents 1 185.4 241.9 -23.4 Net financial debt 1 326.7 257.0 27.1 1 2 Net financial debt / EBITDA 2.8 2.4 Capital employed 1 1,611.4 1,590.0 1.3
Slide 11: Outlook FY 2023
03 Outlook FY 2023 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved Forecast for for fiscal year 2022 fiscal year 2023 Net sales (net of currency effects) -11.5% 7.0 to 11.0% Gross margin 40.7% 43.0 to 45.0% EBIT margin -2.9% 0.0 to 3.0% Dräger Value Added (DVA) EUR -196.2 million EUR -110 to 0 million Drägerwerk AG & Co. KGaA 12
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 9, 2023 Annual Report 2022 Conference call April 28, 2023 Report for the first three months 2023 Conference c
Slide 15: Contact
Contact Thomas Fischler | Head of Treasury & Investor Relations Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 2685 Mail: thomas.fischler@draeger.com Nikolaus Hammerschmidt | Investor Relations Manager Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 8903 Mail: nikolaus.ham
Slide 16: Thank you
Thank you 16
Drägerwerk AG & Co. KGaA — H1 2023 Earnings Presentation on 6ix